{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T10:53:21Z","timestamp":1788260001803,"version":"build-2803163510"},"reference-count":49,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2018,5,1]],"date-time":"2018-05-01T00:00:00Z","timestamp":1525132800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,5,1]],"date-time":"2018-05-01T00:00:00Z","timestamp":1525132800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejso.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Surgical Oncology"],"published-print":{"date-parts":[[2018,5]]},"DOI":"10.1016\/j.ejso.2018.02.001","type":"journal-article","created":{"date-parts":[[2018,2,9]],"date-time":"2018-02-09T06:46:49Z","timestamp":1518158809000},"page":"571-579","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":58,"title":["Neoadjuvant and adjuvant strategies in retroperitoneal sarcoma"],"prefix":"10.1016","volume":"44","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4133-312X","authenticated-orcid":false,"given":"L. Max","family":"Almond","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Gronchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dirk","family":"Strauss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariam","family":"Jafri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel","family":"Ford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anant","family":"Desai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.ejso.2018.02.001_bib1","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1002\/ijc.27711","article-title":"Global estimates of cancer prevalence for 27 sites in the adult population in 2008","volume":"132","author":"Bray","year":"2013","journal-title":"Int J Cancer"},{"issue":"3","key":"10.1016\/j.ejso.2018.02.001_bib2","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1097\/SLA.0000000000000869","article-title":"Lessons learned from the study of 10,000 patients with soft tissue sarcoma","volume":"260","author":"Brennan","year":"2014","journal-title":"Ann Surg"},{"issue":"1","key":"10.1016\/j.ejso.2018.02.001_bib3","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1245\/s10434-014-3965-2","article-title":"Management of primary retroperitoneal sarcoma (RPS) in the adult: a consensus approach from the Trans-Atlantic RPS Working Group","volume":"22","year":"2015","journal-title":"Ann Surg Oncol"},{"issue":"12","key":"10.1016\/j.ejso.2018.02.001_bib4","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.1200\/JCO.2008.21.5467","article-title":"Resection of uninvolved adjacent organs can be part of surgery for retroperitoneal soft tissue sarcoma","volume":"27","author":"Gronchi","year":"2009","journal-title":"J\u00a0Clin Oncol"},{"issue":"5","key":"10.1016\/j.ejso.2018.02.001_bib5","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1097\/SLA.0000000000001447","article-title":"Variability in patterns of recurrence after resection of primary retroperitoneal sarcoma (RPS): a report on 1007 patients from the multi-institutional Collaborative RPS Working Group","volume":"263","author":"Gronchi","year":"2016","journal-title":"Ann Surg"},{"issue":"17","key":"10.1016\/j.ejso.2018.02.001_bib6","doi-asserted-by":"crossref","first-page":"2638","DOI":"10.1002\/cncr.28715","article-title":"Surgical management of localized soft tissue tumors","volume":"120","author":"Gronchi","year":"2014","journal-title":"Cancer"},{"issue":"11","key":"10.1016\/j.ejso.2018.02.001_bib7","doi-asserted-by":"crossref","first-page":"3550","DOI":"10.1245\/s10434-015-4380-z","article-title":"Outcomes following extended surgery for retroperitoneal sarcomas: results from a UK referral centre","volume":"22","author":"Pasquali","year":"2015","journal-title":"Ann Surg Oncol"},{"issue":"Suppl.\u00a03","key":"10.1016\/j.ejso.2018.02.001_bib8","first-page":"102","article-title":"Soft tissue and visceral sarcomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up","volume":"25","year":"2014","journal-title":"Ann Oncol"},{"issue":"6","key":"10.1016\/j.ejso.2018.02.001_bib9","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/s11864-015-0346-4","article-title":"Preoperative therapy for extremity soft tissue sarcomas","volume":"16","author":"Davis","year":"2015","journal-title":"Curr Treat Options Oncol"},{"issue":"5","key":"10.1016\/j.ejso.2018.02.001_bib10","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1007\/s00280-016-3055-1","article-title":"Looking for answers: the current status of neoadjuvant treatment in localized soft tissue sarcomas","volume":"78","author":"Nathenson","year":"2016","journal-title":"Cancer Chemother Pharmacol"},{"issue":"13","key":"10.1016\/j.ejso.2018.02.001_bib11","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1002\/bjs.10305","article-title":"Preoperative radiotherapy in the management of retroperitoneal liposarcoma","volume":"103","author":"Ecker","year":"2016","journal-title":"Br J Surg"},{"issue":"1","key":"10.1016\/j.ejso.2018.02.001_bib12","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0360-3016(99)00546-5","article-title":"High-dose-rate intraoperative radiation therapy (HDR-IORT) for retroperitoneal sarcomas","volume":"47","author":"Alektiar","year":"2000","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"2","key":"10.1016\/j.ejso.2018.02.001_bib13","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1002\/cncr.22005","article-title":"Preoperative radiation therapy with selective dose escalation to the margin at risk for retroperitoneal sarcoma","volume":"107","author":"Tzeng","year":"2006","journal-title":"Cancer"},{"issue":"3","key":"10.1016\/j.ejso.2018.02.001_bib14","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/j.ijrobp.2006.01.028","article-title":"Intraoperative electron-beam therapy for primary and recurrent retroperitoneal soft-tissue sarcoma","volume":"65","author":"Krempien","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"2","key":"10.1016\/j.ejso.2018.02.001_bib15","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1002\/1097-0142(20010715)92:2<359::AID-CNCR1331>3.0.CO;2-Y","article-title":"Prognostic factors in retroperitoneal sarcoma: a multivariate analysis of a series of 165 patients of the French Cancer Center Federation Sarcoma Group","volume":"92","author":"Stoeckle","year":"2001","journal-title":"Cancer"},{"issue":"5","key":"10.1016\/j.ejso.2018.02.001_bib16","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1016\/0360-3016(94)90395-6","article-title":"Outcome and prognosis in retroperitoneal soft tissue sarcoma","volume":"29","author":"Catton","year":"1994","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"3","key":"10.1016\/j.ejso.2018.02.001_bib17","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1177\/107327481101800305","article-title":"Current diagnosis and management of retroperitoneal sarcoma","volume":"18","author":"Mullinax","year":"2011","journal-title":"Cancer Control"},{"issue":"8","key":"10.1016\/j.ejso.2018.02.001_bib18","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1586\/era.09.77","article-title":"Current concepts and future perspectives in retroperitoneal soft-tissue sarcoma management","volume":"9","author":"Thomas","year":"2009","journal-title":"Expert Rev Anticancer Ther"},{"issue":"4","key":"10.1016\/j.ejso.2018.02.001_bib19","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1007\/BF02573869","article-title":"Initial results of a trial of preoperative external-beam radiation therapy and postoperative brachytherapy for retroperitoneal sarcoma","volume":"9","author":"Jones","year":"2002","journal-title":"Ann Surg Oncol"},{"issue":"1","key":"10.1016\/j.ejso.2018.02.001_bib20","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1097\/SLA.0000000000000840","article-title":"Long-term oncologic outcomes after neoadjuvant radiation therapy for retroperitoneal sarcomas","volume":"262","author":"Nussbaum","year":"2015","journal-title":"Ann Surg"},{"issue":"1","key":"10.1016\/j.ejso.2018.02.001_bib21","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S0360-3016(00)01589-3","article-title":"Long-term results of intraoperative electron beam radiotherapy for primary and recurrent retroperitoneal soft tissue sarcoma","volume":"50","author":"Gieschen","year":"2001","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"4","key":"10.1016\/j.ejso.2018.02.001_bib22","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1016\/j.ijrobp.2009.06.074","article-title":"Positive surgical margins in soft tissue sarcoma treated with preoperative radiation: is a postoperative boost necessary?","volume":"77","author":"Al Yami","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"12","key":"10.1016\/j.ejso.2018.02.001_bib23","doi-asserted-by":"crossref","first-page":"3199","DOI":"10.1002\/cncr.26489","article-title":"The significance of a marginal excision after preoperative radiation therapy for soft tissue sarcoma of the extremity","volume":"118","author":"Dagan","year":"2012","journal-title":"Cancer"},{"key":"10.1016\/j.ejso.2018.02.001_bib24","series-title":"Second safety analysis of a phase III randomized study of pre-operative radiotherapy plus surgery versus surgery alone for patients with retroperitoneal sarcoma \u2013 EORTC 62092-22092- STRASS","author":"Bonvalot","year":"2016"},{"issue":"4","key":"10.1016\/j.ejso.2018.02.001_bib25","first-page":"1745","article-title":"Older age modifies oncologic outcome following radiotherapy in soft-tissue sarcoma: a subtype-specific SEER analysis","volume":"36","author":"Yuen","year":"2016","journal-title":"Anticancer Res"},{"key":"10.1016\/j.ejso.2018.02.001_bib26","doi-asserted-by":"crossref","first-page":"87367","DOI":"10.1155\/SRCM\/2006\/87367","article-title":"The radiation response of sarcomas by histologic subtypes: a review with special emphasis given to results achieved with razoxane","volume":"1","author":"Rhomberg","year":"2006","journal-title":"Sarcoma"},{"issue":"4","key":"10.1016\/j.ejso.2018.02.001_bib27","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/S1470-2045(14)70063-4","article-title":"Doxorubicin alone versus intensified doxorubicin plus ifosfamide for first-line treatment of advanced or metastatic soft-tissue sarcoma: a randomised controlled phase 3 trial","volume":"15","author":"Judson","year":"2014","journal-title":"Lancet Oncol"},{"issue":"7","key":"10.1016\/j.ejso.2018.02.001_bib28","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1200\/JCO.1993.11.7.1276","article-title":"An intergroup phase III randomized study of doxorubicin and dacarbazine with or without ifosfamide and mesna in advanced soft tissue and bone sarcomas","volume":"11","author":"Antman","year":"1993","journal-title":"J\u00a0Clin Oncol"},{"issue":"9092","key":"10.1016\/j.ejso.2018.02.001_bib29","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1016\/S0140-6736(97)08165-8","article-title":"Adjuvant chemotherapy for localised resectable soft-tissue sarcoma of adults: meta-analysis of individual data","volume":"350","year":"1997","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.ejso.2018.02.001_bib30","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1200\/JCO.2001.19.5.1238","article-title":"Adjuvant chemotherapy for adult soft tissue sarcomas of the extremities and girdles: results of the Italian randomized cooperative trial","volume":"19","author":"Frustaci","year":"2001","journal-title":"J\u00a0Clin Oncol"},{"issue":"9","key":"10.1016\/j.ejso.2018.02.001_bib31","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1016\/S0959-8049(01)00083-1","article-title":"A\u00a0randomised phase II study on neo-adjuvant chemotherapy for 'high-risk' adult soft-tissue sarcoma","volume":"37","author":"Gortzak","year":"2001","journal-title":"Eur J Cancer"},{"issue":"5","key":"10.1016\/j.ejso.2018.02.001_bib32","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1097\/00000421-200210000-00009","article-title":"Adjuvant epirubicin with or without Ifosfamide for adult soft-tissue sarcoma","volume":"25","author":"Petrioli","year":"2002","journal-title":"Am J Clin Oncol"},{"issue":"3","key":"10.1016\/j.ejso.2018.02.001_bib33","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1002\/cncr.23592","article-title":"A\u00a0systematic meta-analysis of randomized controlled trials of adjuvant chemotherapy for localized resectable soft-tissue sarcoma","volume":"113","author":"Pervaiz","year":"2008","journal-title":"Cancer"},{"issue":"10","key":"10.1016\/j.ejso.2018.02.001_bib34","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1016\/S1470-2045(12)70346-7","article-title":"Adjuvant chemotherapy with doxorubicin, ifosfamide, and lenograstim for resected soft-tissue sarcoma (EORTC 62931): a multicentre randomised controlled trial","volume":"13","author":"Woll","year":"2012","journal-title":"Lancet Oncol"},{"issue":"12","key":"10.1016\/j.ejso.2018.02.001_bib35","doi-asserted-by":"crossref","first-page":"2436","DOI":"10.1093\/annonc\/mdq238","article-title":"Effect of adjuvant chemotherapy on survival in FNCLCC grade 3 soft tissue sarcomas: a multivariate analysis of the French Sarcoma Group Database","volume":"21","author":"Italiano","year":"2010","journal-title":"Ann Oncol"},{"issue":"12","key":"10.1016\/j.ejso.2018.02.001_bib36","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.1093\/annonc\/mdw430","article-title":"Short, full-dose adjuvant chemotherapy (CT) in high-risk adult soft tissue sarcomas (STS): long-term follow-up of a randomized clinical trial from the Italian Sarcoma Group and the Spanish Sarcoma Group","volume":"27","author":"Gronchi","year":"2016","journal-title":"Ann Oncol"},{"issue":"2","key":"10.1016\/j.ejso.2018.02.001_bib37","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1093\/annonc\/mdr138","article-title":"Metastatic angiosarcomas: doxorubicin-based regimens, weekly paclitaxel and metastasectomy significantly improve the outcome","volume":"23","author":"Penel","year":"2012","journal-title":"Ann Oncol"},{"issue":"10","key":"10.1016\/j.ejso.2018.02.001_bib38","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1634\/theoncologist.10-10-833","article-title":"Using single-agent therapy in adult patients with advanced soft tissue sarcoma can still be considered standard care","volume":"10","author":"Sleijfer","year":"2005","journal-title":"Oncologist"},{"issue":"6","key":"10.1016\/j.ejso.2018.02.001_bib39","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/S1470-2045(10)70071-1","article-title":"Neo-adjuvant chemotherapy alone or with regional hyperthermia for localised high-risk soft-tissue sarcoma: a randomised phase 3 multicentre study","volume":"11","author":"Issels","year":"2010","journal-title":"Lancet Oncol"},{"issue":"14","key":"10.1016\/j.ejso.2018.02.001_bib40","doi-asserted-by":"crossref","first-page":"3156","DOI":"10.1200\/JCO.2002.07.146","article-title":"Response to neoadjuvant chemotherapy combined with regional hyperthermia predicts long-term survival for adult patients with retroperitoneal and visceral high-risk soft tissue sarcomas","volume":"20","author":"Wendtner","year":"2002","journal-title":"J\u00a0Clin Oncol"},{"issue":"13","key":"10.1016\/j.ejso.2018.02.001_bib41","doi-asserted-by":"crossref","first-page":"3872","DOI":"10.1245\/s10434-017-6105-y","article-title":"Long-term follow-up and post-relapse outcome of patients with localized retroperitoneal sarcoma treated in the Italian sarcoma group-soft tissue sarcoma (ISG-STS) protocol 0303","volume":"24","author":"De Sanctis","year":"2017","journal-title":"Ann Surg Oncol"},{"issue":"19","key":"10.1016\/j.ejso.2018.02.001_bib42","doi-asserted-by":"crossref","first-page":"3378","DOI":"10.1200\/JCO.2000.18.19.3378","article-title":"Impact of neoadjuvant chemotherapy on postoperative morbidity in soft tissue sarcomas","volume":"18","author":"Meric","year":"2000","journal-title":"J\u00a0Clin Oncol"},{"issue":"16","key":"10.1016\/j.ejso.2018.02.001_bib43","doi-asserted-by":"crossref","first-page":"3092","DOI":"10.1200\/JCO.2003.01.143","article-title":"Phase I trial of preoperative concurrent doxorubicin and radiation therapy, surgical resection, and intraoperative electron-beam radiation therapy for patients with localized retroperitoneal sarcoma","volume":"21","author":"PW1","year":"2003","journal-title":"J\u00a0Clin Oncol"},{"issue":"7","key":"10.1016\/j.ejso.2018.02.001_bib44","doi-asserted-by":"crossref","first-page":"2150","DOI":"10.1245\/s10434-014-3616-7","article-title":"A\u00a0contemporary large single-institution evaluation of resected retroperitoneal sarcoma","volume":"21","author":"Bremjit","year":"2014","journal-title":"Ann Surg Oncol"},{"issue":"10","key":"10.1016\/j.ejso.2018.02.001_bib45","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1016\/j.ejso.2015.07.014","article-title":"Impact of chemotherapy on survival in surgically resected retroperitoneal sarcoma","volume":"41","author":"Miura","year":"2015","journal-title":"Eur J Surg Oncol"},{"issue":"6","key":"10.1016\/j.ejso.2018.02.001_bib46","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1586\/14737140.2014.885840","article-title":"Emerging therapies for adult soft tissue sarcoma","volume":"14","author":"Radaelli","year":"2014","journal-title":"Expert Rev Anticancer Ther"},{"issue":"1","key":"10.1016\/j.ejso.2018.02.001_bib47","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1080\/0284186X.2016.1234068","article-title":"Pazopanib in advanced vascular sarcomas: an EORTC soft tissue and bone sarcoma group (STBSG) retrospective analysis","volume":"56","author":"Kollar","year":"2017","journal-title":"Acta Oncol"},{"issue":"8","key":"10.1016\/j.ejso.2018.02.001_bib48","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1056\/NEJMoa020890","article-title":"Addition of ifosfamide and etoposide to standard chemotherapy for Ewing's sarcoma and primitive neuroectodermal tumor of bone","volume":"348","author":"Grier","year":"2003","journal-title":"N\u00a0Engl J Med"},{"issue":"20","key":"10.1016\/j.ejso.2018.02.001_bib49","doi-asserted-by":"crossref","first-page":"3284","DOI":"10.1200\/JCO.2009.22.9864","article-title":"Primary disseminated multifocal Ewing sarcoma: results of the Euro-EWING 99 trial","volume":"28","author":"Ladenstein","year":"2010","journal-title":"J\u00a0Clin Oncol"}],"container-title":["European Journal of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0748798318302944?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0748798318302944?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T01:25:05Z","timestamp":1760059505000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0748798318302944"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5]]},"references-count":49,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2018,5]]}},"alternative-id":["S0748798318302944"],"URL":"https:\/\/doi.org\/10.1016\/j.ejso.2018.02.001","relation":{},"ISSN":["0748-7983"],"issn-type":[{"value":"0748-7983","type":"print"}],"subject":[],"published":{"date-parts":[[2018,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Neoadjuvant and adjuvant strategies in retroperitoneal sarcoma","name":"articletitle","label":"Article Title"},{"value":"European Journal of Surgical Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejso.2018.02.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Crown Copyright \u00a9 2018 Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}